American Association of Neuromuscular & Electrodiagnostic Medicine

Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology

Retrieved on: 
Tuesday, February 28, 2023
Linda, Medicine, Loma Linda University Medical Center, Children's Specialized Hospital, School, Inner circle, Texas Medical Association, Patient, BPN, DSM-IV codes, American Board of Psychiatry and Neurology, American Medical Association, Internal medicine, Veterans Health Administration, James J. Peters VA Medical Center, American Academy of Neurology, American Association of Neuromuscular & Electrodiagnostic Medicine, Universidad del Noreste, Suite, Texas Institute for Genomic Medicine, Wilson N. Jones Regional Medical Center, Seizure, Rehabilitation hospital, EMG, Medical director, Fellow, Multimedia, American Board of Commissioners for Foreign Missions, ABPN, NCV, Electrodiagnostic medicine, Psychiatry, American Academy, Skiing, Veterinary medicine, Nursing, Pharmaceutical industry, Epilepsy, Neurology

SHERMAN, Texas, Feb. 28, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.

Key Points: 
  • SHERMAN, Texas, Feb. 28, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.
  • Dr. Matus earned a medical degree from the School of Medicine at The Universidad de San Carlos de Guatemala in 1982.
  • He finished a Neurology Residency in 1995 at the Loma Linda University Medical Center in Loma Linda, CA.
  • Dr. Matus is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN).

Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting® 2022

Retrieved on: 
Friday, November 4, 2022
Company, Tern, Research, SHBG, BCR, Obesity, Risk, GLOBE, NASH, Triglyceride, Safety, American Association of Neuromuscular & Electrodiagnostic Medicine, Fibrosis, Fatty liver disease, Itch, Non-alcoholic fatty liver disease, Terminology, Institute of Liver and Biliary Sciences, Liver disease, AASLD, FXR, THR, DUET, Pharmacology, Annual report, Clinical trial, LDL, Metabolism, Inflammation, Liver, MRI, Lipid metabolism, Gene, Association, Patient, Pharmacokinetics, American Association, Pharmaceutical industry

FOSTER CITY, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that the company is presenting positive clinical data from its Phase 1 study of TERN-501, a thyroid hormone receptor beta (THR-β) agonist in development for the treatment of NASH. The results are being highlighted in a poster presentation at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4-8, 2022.

Key Points: 
  • The results are being highlighted in a poster presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4-8, 2022.
  • Results showed that among the 24 treated participants TERN-501 was generally well tolerated and exhibited dose-dependent pharmacokinetics with low variability.
  • Terns will review the ongoing Phase 2a DUET trial ( NCT05415722 ) design and objectives in a second presentation at The Liver Meeting.
  • Terns reported positive top-line single-ascending and multiple-ascending dose (SAD/MAD) data from Phase 1 proof of concept clinical trial in November 2021.

Wiley Launches ‘Partner Solutions’ Division in Research to Support the Transition to Open Access Publishing

Retrieved on: 
Monday, October 17, 2022
Research, Publishing, Entertainment, Communications, Books, Other Education, University, Primary, Secondary, Science, Education, Knowledge, LinkedIn, Editorial, Mission statement, General manager, Diagnosis, Society, Education, Organization, International League Against Epilepsy, NYSE, Library, Twitter, Frankfurt Book Fair, Electrical engineering technology, Institute, Electronics, Goal, Epilepsy, ACM, Publishing, Industry, Wiley-Blackwell, AAAS, American Association, Association, Fred Brooks, IEEE, American Association of Neuromuscular & Electrodiagnostic Medicine, Classification, Manuscript, Electricity, Solution, Â, Research Institute for Advanced Computer Science, Leadership, Management, Pharmaceutical industry, Facebook, Research

In the run-up to the Frankfurt Book Fair, Wiley (NYSE: WLY), a global leader in research and education, today announced Wiley Partner Solutions , a new division within its Research business.

Key Points: 
  • In the run-up to the Frankfurt Book Fair, Wiley (NYSE: WLY), a global leader in research and education, today announced Wiley Partner Solutions , a new division within its Research business.
  • Wiley Partner Solutions serves associations, scientific publishers, societies and corporations as they transform their business strategies and publishing processes in the open research era.
  • Wiley Partner Solutions delivers a broad array of digital platforms, publishing solutions, and services to help partners scale, collaborate, and accelerate their publishing programs, while at the same time supporting the value chain of scholarly publishing.
  • Wiley Partner Solutions will operate separately from Wileys Research Publishing business and will be reported as Research Solutions or Research Partner Solutions in the Companys public filings and financial statements.

American Association for Physician Leadership Announces Partnership with Michigan Health & Hospital Association

Retrieved on: 
Thursday, September 22, 2022
Health, American Hospital Association, MD, Association, CPE, Organization, DO, Partnership, American Association, Certification, Physician, Tool, CEO, Chief executive officer, Goal, American Association of Neuromuscular & Electrodiagnostic Medicine, Hospital, MHA, Medicine, Management, AAPL

WASHINGTON, Sept. 22, 2022 /PRNewswire/ --The American Association for Physician Leadership (AAPL) announced today a partnership with the Michigan Health & Hospital Association (MHA) that will make leadership education and training more easily accessible.

Key Points: 
  • WASHINGTON, Sept. 22, 2022 /PRNewswire/ --The American Association for Physician Leadership (AAPL) announced today a partnership with the Michigan Health & Hospital Association (MHA) that will make leadership education and training more easily accessible.
  • The new MHA Physician Membership category focuses on issues pertaining to physicians, including physician integration and interaction within hospitals, healthcare systems and physician practices, and will include membership in AAPL.
  • "We believe this partnership is essential to furthering our goal of encouraging partnerships between the physician and hospital leadership communities," said MHA chief medical officer Gary Roth, DO.
  • The American Association for Physician Leadership (AAPL) is focused on the personal transformation of all physicians, and through them the organizations they serve.

Pharnext: Findings on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A From ‘Real-World’ Digital Lifestyle Study, CMT&Me, to be Presented at the American Association of Neuromuscular & Electrodia

Retrieved on: 
Thursday, September 15, 2022
Therapy, II, ISIN, Prevalence, Convention center, Neurodegeneration, Poster, Life, Muscle atrophy, Medical Affairs Bureau, American Association of Neuromuscular & Electrodiagnostic Medicine, American Association, Electrodiagnostic medicine, AANEM, Charcot–Marie–Tooth disease, Patient, Wheelchair, PMP22, III, Schwann cell, Pain, Quality of life, CMT, Walking, Running, Degenerative disease, CET, Regulatory News Service, Conference, Association, Occupational therapy, Gaylord Opryland Resort & Convention Center, Pharmaceutical industry, Security (finance), Medical device, Television

Pharnext: Findings on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A From Real-World Digital Lifestyle Study, CMT&Me, to be Presented at the American Association of Neuromuscular & Electrodia

Key Points: 
  • Pharnext: Findings on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A From Real-World Digital Lifestyle Study, CMT&Me, to be Presented at the American Association of Neuromuscular & Electrodia
    Dissemination of a French Regulatory News, transmitted by EQS Group.
  • The conference is taking place from September 21-24, 2022, in-person and with an option to participate virtually, at Gaylord Opryland Resort & Conference Center in Nashville, Tennessee.
  • Charcot-Marie-Tooth (CMT) disease encompasses a heterogeneous group of inherited, severe, debilitating, progressive and chronic peripheral neuropathies.
  • The genetic mutation responsible for CMT1A is a duplication of the PMP22 gene coding for a peripheral myelin protein.

The Growing Relevance of Leadership Skills for Physicians: AAPL Releases its 100th Podcast Featuring Luminaries in Healthcare

Retrieved on: 
Wednesday, June 29, 2022
Leadership, CEO, HealthEquity, American Association of Neuromuscular & Electrodiagnostic Medicine, Patient, DO, AAPL, Chief executive officer, Podcasts (software), The Wall Street Journal, The Washington Post, Health care, Community, Mindfulness, Association, Health, MPH, Organization, Doctor of Philosophy, American Association, Physician, JD, Medicine, Interview, Race (human categorization), National Geographic, Mindfulness Day, Conference, Management, Spotify, MD

In the 100th episode of "SoundPractice," AAPL podcast host Mike Sacopulos speaks with a variety of global leaders in healthcare: Listen to the podcast.

Key Points: 
  • In the 100th episode of "SoundPractice," AAPL podcast host Mike Sacopulos speaks with a variety of global leaders in healthcare: Listen to the podcast.
  • This roundup of interview excerpts with national and international leaders includes expert commentary from Dr. Peter Angood, CEO of AAPL.
  • The bi-weekly podcast features conversations with industry leaders and delivers practical information and fresh perspectives for physician leaders and those running healthcare systems.
  • The American Association for Physician Leadership (AAPL) is focused on the personal transformation of all physicians, and through them the organizations they serve.

Paul Stamets to Present at LIFE ITSELF Event!

Retrieved on: 
Wednesday, May 25, 2022
New York Mycological Society, Disease, Medicine, Research, Food, Oklahoma Center for the Advancement of Science and Technology, CBS, LIFE, Gordon, Multimedia, TEDMED, Government, Book, Health, Association, American Association of Neuromuscular & Electrodiagnostic Medicine, Americas Society, North American Mycological Association, Mycology, Culture, Industry, Partnership, Star Trek: Discovery, AAAS, Technology, Food and Drug Administration, Paul Stamets, NAMA, CNN, American Association, MSA, Medical device, Pharmaceutical industry

OLYMPIA, Wash., May 25, 2022 /PRNewswire/ -- Renowned mycologist, Paul Stamets, will be speaking at the 2022 LIFE ITSELF event alongside thought leaders working at the intersection of health and medicine.

Key Points: 
  • OLYMPIA, Wash., May 25, 2022 /PRNewswire/ -- Renowned mycologist, Paul Stamets, will be speaking at the 2022 LIFE ITSELF event alongside thought leaders working at the intersection of health and medicine.
  • Renowned mycologist, Paul Stamets, will be presenting at the 2022 LIFE ITSELF event.
  • Paul's work has even entered into popular culture with astromycologist "Lieutenant Paul Stamets" in the 'Star Trek: Discovery' series on CBS.
  • The visionary research and stewardship of Paul Stamets has led to significant breakthroughs revealing the power and potential of mushrooms and mushroom mycelium.

League Adds Industry Leadership to Advisory Board with New Member, Promotion

Retrieved on: 
Tuesday, May 24, 2022
Health, General Health, Twilio, MBA, COO, Providence Health & Services, Leadership, Solution, Welsh, Platform as a service, Association, American Association of Neuromuscular & Electrodiagnostic Medicine, Research, Man, Butler, Technology, EVP, Providence, Faculty, Population health, Love, CMO, American Association, Stowe, CFO, MD, CEO, Pharmaceutical industry, Management, Service, Walgreens, League, Gelesis

League , the leading healthcare consumer experience platform, today announced changes to its advisory board that involve two healthcare industry veterans.

Key Points: 
  • League , the leading healthcare consumer experience platform, today announced changes to its advisory board that involve two healthcare industry veterans.
  • Harry Leider, MD, MBA, a former Walgreens executive and current chief medical officer and executive vice president of Gelesis, will join the advisory board as a new member.
  • A healthcare operating partner at Welsh, Carson, Anderson and Stowe who formerly led Providence Health and Services, Butler joined Leagues advisory board in 2021.
  • Dr. Leider is a current faculty member and former president and chairman of the board at the American Association for Physician Leadership.

Jose A. Matus is recognized by Continental Who's Who

Retrieved on: 
Tuesday, February 15, 2022
Linda, Seizure, Patient, Universidad del Noreste, American Board of Psychiatry and Neurology, Education, Indian Medical Association, Electrodiagnostic medicine, Texas Medical Association, CA, Children's Specialized Hospital, Veterans Health Administration, American Board of Commissioners for Foreign Missions, NCV, Loma Linda University Medical Center, American Medical Association, American Association of Neuromuscular & Electrodiagnostic Medicine, Rehabilitation hospital, Internal medicine, ABPN, EMG, Lists of diseases, Hospital, American Academy, Texas Institute for Genomic Medicine, San Francisco VA Medical Center, Wilson N. Jones Regional Medical Center, Association, Skiing, Continental, American Association, School, Psychiatry, Medical director, Fellow, American Academy of Neurology, Pharmaceutical industry, Medicine, Medicine, Epilepsy, Neurology

To pursue his education, Dr. Matus received his Medical degree from the School of Medicine at The Universidad de San Carlos de Guatemala in Guatemala in 1982.

Key Points: 
  • To pursue his education, Dr. Matus received his Medical degree from the School of Medicine at The Universidad de San Carlos de Guatemala in Guatemala in 1982.
  • Dr. Matus is Fellowship trained in Epilepsy through the Kiffin Penry Epilepsy Mini Fellowship Program, in Winston-Salem, NC.
  • As a result of his training, Dr. Matus is board-certified in Neurology by the American Board of Psychiatry and Neurology (ABPN).
  • Dr. Matus sees patients for acute neurology care, as well as performing neuro-diagnostic procedures like EMG, NCV EEGs, and Carotid Ultrasounds.

mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022

Retrieved on: 
Thursday, February 3, 2022
Lazarus, CEO, American Association, Patient, Leadership, Health, American Association of Neuromuscular & Electrodiagnostic Medicine, Philosophy, Medical director, Trial of the century, Clinical trial, Health professional, Temple University, Doximity, Efficiency, Population, Marketing, Editorial board, Boston University, Travel, Association, Patient safety, MBA, Medical device, Pharmaceutical industry, Management, Medical imaging, Psychology

BRACKNELL, England, Feb. 3, 2022 /PRNewswire/ -- mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director.

Key Points: 
  • BRACKNELL, England, Feb. 3, 2022 /PRNewswire/ -- mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director.
  • DrLazarus will also be speaking atSCOPE 2022on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for remote patient visits improves data integrity and monitoring.
  • He will be sharing how the latest medical technologies meet patient care to create remarkable patient experiences, and the important factors to consider when selecting Healthcare Professionals for mobile health patient visits.
  • Tarquin Scadding-Hunt, CEO of mdgroup, said: "Dr Lazarus' background in clinical development, patient safety and medical marketing brings a wealth of experience to the mdgroup.